BRPI0413682A - compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos - Google Patents
compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usosInfo
- Publication number
- BRPI0413682A BRPI0413682A BRPI0413682-9A BRPI0413682A BRPI0413682A BR PI0413682 A BRPI0413682 A BR PI0413682A BR PI0413682 A BRPI0413682 A BR PI0413682A BR PI0413682 A BRPI0413682 A BR PI0413682A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- methods
- extermination
- microorganism
- pharmaceutical composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 230000000813 microbial effect Effects 0.000 title abstract 2
- 244000005700 microbiome Species 0.000 title abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- QAZLUNIWYYOJPC-UHFFFAOYSA-M sulfenamide Chemical compound [Cl-].COC1=C(C)C=[N+]2C3=NC4=CC=C(OC)C=C4N3SCC2=C1C QAZLUNIWYYOJPC-UHFFFAOYSA-M 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
"COMPOSTOS, COMPOSIçãO FARMACêUTICA E RESPECTIVOS MéTODOS DE PREPARAçãO DE TRATAMENTO DE INFECçãO MICROBIANA E DE EXTERMìNIO DE MICROORGANISMO E USOS". São apresentados compostos de óxido de sulfenamida da fórmula geral (I), em que A, R~ 1~, R~ 2~, X~ 1~, X~ 1~<39>, X~ 2~, X~ 2~<39>, X~ 3~, X~ 4~, X~ 4~<39>, X~ 5~ e X~ 5~<39> definem muitas variáveis e em que q é O ou 1 e p é 1 ou 2. Os compostos apresentados nos exemplos são os compostos de óxido de sulfenamida galactofuranosil e glucofuranosil, em que a variável A é o oxigenio. Também são apresentados métodos de síntese dos compostos de fórmula geral (I), composições farmacêuticas que os contenham e métodos de uso no tratamento de pacientes que estejam sofrendo de infecção microbiana.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003904501A AU2003904501A0 (en) | 2003-08-21 | Novel compounds III | |
| AU2003904500A AU2003904500A0 (en) | 2003-08-21 | Novel compounds II | |
| PCT/AU2004/001110 WO2005019236A1 (en) | 2003-08-21 | 2004-08-20 | Novel sulfenamide oxides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0413682A true BRPI0413682A (pt) | 2006-10-24 |
Family
ID=34218927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0413682-9A BRPI0413682A (pt) | 2003-08-21 | 2004-08-20 | compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1664071A1 (pt) |
| JP (1) | JP2007502778A (pt) |
| BR (1) | BRPI0413682A (pt) |
| CA (1) | CA2535800A1 (pt) |
| MX (1) | MXPA06001974A (pt) |
| RU (1) | RU2006108577A (pt) |
| WO (1) | WO2005019236A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7601716B2 (en) | 2006-05-01 | 2009-10-13 | Cephalon, Inc. | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors |
| BRPI0923225A2 (pt) | 2008-12-02 | 2016-10-04 | Chiralgen Ltd | metodo para sintese de acidos nucleicos modificados no atomo de fosforo |
| EP2451461A4 (en) | 2009-07-06 | 2013-05-29 | Ontorii Inc | NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF |
| DK2620428T3 (da) | 2010-09-24 | 2019-07-01 | Wave Life Sciences Ltd | Asymmetrisk hjælpegruppe |
| CN107365339A (zh) | 2011-07-19 | 2017-11-21 | 波涛生命科学有限公司 | 合成官能化核酸的方法 |
| WO2014010250A1 (en) | 2012-07-13 | 2014-01-16 | Chiralgen, Ltd. | Asymmetric auxiliary group |
| EP3094728B1 (en) | 2014-01-16 | 2022-03-09 | Wave Life Sciences Ltd. | Chiral design |
| WO2018035380A1 (en) | 2016-08-17 | 2018-02-22 | Solstice Biologics, Ltd. | Polynucleotide constructs |
| US11597744B2 (en) | 2017-06-30 | 2023-03-07 | Sirius Therapeutics, Inc. | Chiral phosphoramidite auxiliaries and methods of their use |
| PH12022551379A1 (en) | 2019-12-06 | 2023-05-03 | Vertex Pharma | Substituted tetrahydrofurans as modulators of sodium channels |
| BR112022024071A2 (pt) | 2020-05-27 | 2022-12-20 | Axial Therapeutics Inc | Compostos moduladores de tlr2, composições farmacêuticas e usos dos mesmos |
| SI4347031T1 (sl) | 2021-06-04 | 2026-01-30 | Vertex Pharmaceuticals Incorporated | N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1646513A (zh) * | 2002-02-22 | 2005-07-27 | 格里菲斯大学 | 抗微生物剂 |
-
2004
- 2004-08-20 MX MXPA06001974A patent/MXPA06001974A/es not_active Application Discontinuation
- 2004-08-20 RU RU2006108577/04A patent/RU2006108577A/ru not_active Application Discontinuation
- 2004-08-20 WO PCT/AU2004/001110 patent/WO2005019236A1/en not_active Ceased
- 2004-08-20 EP EP04761147A patent/EP1664071A1/en not_active Withdrawn
- 2004-08-20 JP JP2006523486A patent/JP2007502778A/ja active Pending
- 2004-08-20 CA CA002535800A patent/CA2535800A1/en not_active Abandoned
- 2004-08-20 BR BRPI0413682-9A patent/BRPI0413682A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06001974A (es) | 2006-05-31 |
| EP1664071A1 (en) | 2006-06-07 |
| RU2006108577A (ru) | 2007-09-27 |
| JP2007502778A (ja) | 2007-02-15 |
| WO2005019236A1 (en) | 2005-03-03 |
| CA2535800A1 (en) | 2005-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074657L (no) | Nitrogenholdige aromatiske ringforbindelser | |
| SE0104340D0 (sv) | New compounds | |
| ATE242213T1 (de) | Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz | |
| BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
| ATE221521T1 (de) | Azolylpiperazinylphenyloxazolidinone als antimikrobielle mittel | |
| NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
| BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
| ATE245152T1 (de) | Dioxocyclopentylhydroxamsäure | |
| BR0313266A (pt) | Compostos, respectivos processos de preparação e uso, formulação farmacêutica e métodos de prevenção e/ou tratamento de um distúrbio mediado pelo receptor de mglur5 e de inibição da ativação de receptores de mglur5 | |
| MY140488A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| TR200302242T2 (tr) | Protein kinaz önleyicileri olarak pirolopirimidinler | |
| AP2003002915A0 (en) | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis. | |
| BR0014596A (pt) | Derivado de pirimidina, uso do mesmo, composição farmacêutica, e, método de tratar doenças ou condições médicas mediadas por citocinas | |
| BRPI0411582A (pt) | substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso | |
| SE0001899D0 (sv) | New compounds | |
| SE0104251D0 (sv) | Novel compounds | |
| ATE396174T1 (de) | Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
| AU2002248384A1 (en) | Serpin drugs for treatment of hiv infection and method of use thereof | |
| PL354030A1 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
| DE60211539D1 (de) | Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion | |
| NO20072089L (no) | Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav | |
| YU40002A (sh) | Antipikornavirusna jedinjenja i kompozicije, njihove farmaceutske upotrebe, i materijali za njihove sinteze | |
| BRPI0413684A (pt) | compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos | |
| SE9902765D0 (sv) | Novel compounds | |
| SE9903894D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |